The startup has developed a scalable microparticle coating technology for a multi-particulate drug delivery system that enhances oral liquid-modified release applications. This system enables pharmaceutical companies to improve drug effectiveness, tolerability, and patient compliance through features like taste-masking and targeted gastrointestinal delivery.
Funding
$650K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many orally administered drugs have limitations in terms of taste, controlled release, and targeted delivery within the gastrointestinal tract, leading to reduced patient compliance and suboptimal therapeutic outcomes. Traditional methods of modifying drug release profiles and masking unpleasant tastes can be inefficient and lack precision.
Solution
FluidPharma has developed a microparticle coating technology designed for multi-particulate drug delivery systems, enhancing oral liquid-modified release applications. This technology enables pharmaceutical companies to improve drug effectiveness, tolerability, and patient compliance. The core innovation lies in the scalable coating process that allows for precise control over drug release kinetics and targeted delivery to specific regions of the gastrointestinal tract. By encapsulating drug particles within specialized coatings, FluidPharma's system effectively masks unpleasant tastes, protects the drug from degradation in the stomach, and ensures optimal absorption in the intestines. This leads to improved bioavailability, reduced side effects, and enhanced therapeutic efficacy.
Target Audience
The primary customers are pharmaceutical companies seeking to improve the performance and patient acceptability of their orally administered drugs, as well as contract development and manufacturing organizations (CDMOs) looking to expand their formulation capabilities.
Features
- Scalable microparticle coating technology for multi-particulate drug delivery systems
- Precise control over drug release kinetics for immediate, delayed, or extended release profiles
- Taste-masking capabilities to improve palatability and patient compliance
- Targeted gastrointestinal delivery to optimize drug absorption and minimize side effects
- Compatibility with a wide range of drug compounds and formulation types